Filing Details

Accession Number:
0000711377-10-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-01 16:41:26
Reporting Period:
2010-09-29
Filing Date:
2010-10-01
Accepted Time:
2010-10-01 16:41:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-29 4,400 $6.75 817,797 No 4 M Direct
Common Stock Disposition 2010-09-29 4,400 $34.39 813,697 No 4 S Direct
Common Stock Acquisiton 2010-09-30 1,958 $9.09 815,355 No 4 M Direct
Common Stock Disposition 2010-09-30 1,958 $34.04 813,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Options (Right to buy) Disposition 2010-09-29 4,400 $0.00 4,400 $6.75
Common Stock Common Stock Option (right to buy) Disposition 2010-09-30 1,958 $0.00 1,958 $9.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
143,165 2013-10-10 No 4 M Direct
141,207 2014-12-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 194,320 Indirect See Note #1
Footnotes
  1. Shares held in trust for the benifit of Mr. Herbert's wife Judith Herbert
  2. The options were granted 10/10/03 as non-qualified options with 10 year lives. The options vested 33% per year for 3 years
  3. The options were granted 12/21/04 as non-qualifed options with 10 year lives. The options vested 33% per year for 3 years.